Harbour Capital Advisors, LLC Bio N Tech Se Transaction History

Harbour Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$118.43 - $186.05 $28,660 - $45,024	-242 Reduced 3.85%	6,043 $0
Q4 2021 Jan 12, 2022	SELL	$216.64 - $362.52 $9,748 - $16,313	-45 Reduced 0.71%	6,285 $1.62 Million
Q3 2021 Oct 13, 2021	BUY	$205.93 - $447.23 $37,067 - $80,501	180 Added 2.93%	6,330 $1.73 Million
Q1 2021 Apr 12, 2021	BUY	$85.73 - $119.5 $527,239 - $734,925	6,150 New	6,150 $671,000
Q4 2020 Jan 12, 2021	SELL	$72.71 - $129.54 $447,166 - $796,671	-6,150 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$38.58 - $66.74 $237,267 - $410,450	6,150 New	6,150 $410,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.